This HTML5 document contains 145 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1136/
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42766135
rdf:type
wikibase:Item
schema:description
scientific article published on September 2007 სამეცნიერო სტატია מאמר מדעי vetenskaplig artikel wissenschaftlicher Artikel научна статия artikulong pang-agham সেপ্টেম্বর ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2007年論文 мақолаи илмӣ teaduslik artikkel 2007年論文 articolo scientifico wetenschappelijk artikel 2007年论文 scientific article published on September 2007 научни чланак artigo científico บทความทางวิทยาศาสตร์ 2007年论文 article scientific article científic tieteellinen artikkeli vedecký článok scienca artikolo 2007年の論文 научная статья artículu científicu espublizáu en 2007 vitskapeleg artikkel 2007年论文 naučni članak 2007年論文 videnskabelig artikel научни чланак scientific article published on September 2007 artigo científico artykuł naukowy 2007年论文 2007 nî lūn-bûn bilimsel makale article scientifique 2007年论文 artikull shkencor مقالة علمية نشرت في سبتمبر 2007 artikel ilmiah vitenskapelig artikkel 2007年論文 artículo científico publicado en 2007 2007年論文 vědecký článek articol științific επιστημονικό άρθρο 2007年论文 bài báo khoa học 2007년 논문 tudományos cikk artigo científico наукова стаття, опублікована у вересні 2007
p:P577
wds:Q42766135-575D26CA-6E53-4252-B81B-39A71C1C5FEC
wdt:P577
2007-09-01T00:00:00Z
p:P407
wds:Q42766135-67E1C8D5-EC7F-4790-9A6E-772380504D90
wdt:P407
wd:Q1860
p:P2860
wds:Q42766135-12F021E8-40D3-49F7-B53D-430EEDB6452C wds:Q42766135-51A02CF8-4761-4158-891A-B14235EC3FCC wds:Q42766135-5D9EB9D6-7D74-4D53-9358-7F876E1C910F wds:Q42766135-AC57312C-4F79-4575-821A-E9397F9356F4 wds:Q42766135-D07C6AF8-FBFF-4641-BCED-855B9DD2EFFD wds:Q42766135-DE238278-617F-42FC-929C-9A2F071E0D5D wds:Q42766135-F3ABB283-CD9B-4AC3-9253-5FF6F78630C5
wdt:P2860
wd:Q44738594 wd:Q36164122 wd:Q22252936 wd:Q24247429 wd:Q35869780 wd:Q43517025 wd:Q36085865
p:P2093
wds:Q42766135-FCAC0B0F-5DDB-44B2-B80D-05CFB34C34B9 wds:Q42766135-FBA2AD46-A87C-4A73-8633-3A5924243AAD wds:Q42766135-8A1DFD60-DE0A-4B7C-B01F-382713C4523F wds:Q42766135-72299503-9A7B-41F6-90D0-9005C9DBCD02 wds:Q42766135-70BD0A64-603D-4791-B4C5-57233296BE22 wds:Q42766135-C3983631-5A69-4C2D-A4B7-C7E7A635F3D0 wds:Q42766135-C57C4AA5-236A-4F26-AE81-52A3793D8B1A wds:Q42766135-BE289482-30C4-4CC8-AE14-35F54BE89EEC wds:Q42766135-9AC044F5-90F9-4BF4-AB7D-E1E7F4704B9A wds:Q42766135-A6F596E2-7B54-49C3-A0DC-A1789C91DB00 wds:Q42766135-2CE561DA-0DE6-4C09-9816-AF521FBB947C wds:Q42766135-27894A8E-0B8D-490D-BFBF-FBE5872B69FA wds:Q42766135-0E92C7CB-4D6E-4977-BA01-8B1E4CF36C34 wds:Q42766135-5804FECB-074F-4FA8-A3AE-19ED8B1DBA7B wds:Q42766135-4B94A4E9-208E-4A37-BCA4-D99F893164A3 wds:Q42766135-4AFD635A-464B-4E75-8783-23A94C75EB78
wdt:P2093
P A van Doorn J Meulstee W H J P Linssen J A P Hiel M Scheltens-de Boer M J J Prick F Visscher C G Faber P Y K van den Bergh J A van Leusden I N van Schaik R van Koningsveld M P J Garssen I S J Merkies C J M Sindic A M Boon
rdfs:label
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study
skos:prefLabel
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study
schema:name
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study
p:P50
wds:Q42766135-041A84DB-F2B7-4121-A166-E5ED8CB35654 wds:Q42766135-F663BC3C-DEF4-436A-B39D-01D910D6BBE8
wdt:P50
wd:Q110190274 wd:Q56999697
p:P1476
wds:Q42766135-7C29AF3D-7D9F-4BBA-9FD2-68C3BE80088C
wdt:P1476
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study
p:P304
wds:Q42766135-50F630AB-00C3-4C87-8169-1A723315B302
wdt:P304
1012-1013
p:P31
wds:Q42766135-37C3C1D7-DA1D-466F-BA9A-16DC6837ABDE wds:Q42766135-0c6ae530-587c-41e7-8d66-eec0205afd7a
wdt:P31
wd:Q13442814 wd:Q2782326
p:P921
wds:Q42766135-8741E0D5-C2BE-4F57-938C-648DE4EEB4F2
wdt:P921
wd:Q205214
p:P698
wds:Q42766135-26FF89F0-BC94-4870-9669-099A162E2989
wdtn:P698
n10:17702789
wdt:P698
17702789
p:P1433
wds:Q42766135-4168FDEA-A6F3-406C-956D-DB8ED355CE9E
wdt:P1433
wd:Q1599804
p:P433
wds:Q42766135-CCE6E8A0-A7AB-421C-AC8D-98E4B8CC9F79
p:P478
wds:Q42766135-9618CFEF-7A15-424F-B626-37A294267802
wdt:P433
9
wdt:P478
78
p:P356
wds:Q42766135-851DB6CE-EB9B-4432-B46E-EC014CE7D184
wdtn:P356
n11:JNNP.2006.102731
wdt:P356
10.1136/JNNP.2006.102731
p:P5875
wds:Q42766135-CBF3D7AE-9330-4483-B4FC-62AF05E9BD8D
wdt:P5875
6136577
p:P932
wds:Q42766135-E79D5E8C-64FA-4C5E-9C33-4284EDD7E535
wdt:P932
2117875